Evidence map›Paper›PMID 38697379›Full record

ArticleNeuroscience and biobehavioral reviews2024

Exploring the impact of music on response to ketamine/esketamine: A scoping review.

Mina Kheirkhah, Allison C Nugent, Alicia A Livinski, Lucinda Neely, Sara C Johnson, Ioline D Henter, Shahaboddin Dabaghi Varnosfaderani, Rebecca B Price, Nadia Hejazi, Mani Yavi and 4 more

Abstract readScoping Review
PubMed Full text at PMC Publisher
In one paragraph

Article in Neuroscience and biobehavioral reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mina KheirkhahExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA; Department of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany. Electronic address: mina.kheirkhahrahimabadi@nih.gov.
Allison C NugentMagnetoencephalography Core, National Institute of Mental Health, Bethesda, MD, USA.
Alicia A LivinskiNIH Library, Office of Research Services, Office of the Director, National Institutes of Health, Bethesda, MD, USA.
Lucinda NeelyExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Sara C JohnsonDepartment of Psychological Sciences, University of Connecticut, USA.
Ioline D HenterExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Shahaboddin Dabaghi VarnosfaderaniCenter for Cognitive Science, Rheinland-Pfälzische Technische Universität Kaiserslautern-Landau, Kaiserslautern, Germany.
Rebecca B PriceDepartments of Psychiatry and Psychology, University of Pittsburgh, Pittsburgh, PA, USA.
Nadia HejaziExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Mani YaviExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.
Hamidreza JamalabadiDepartment of Psychiatry and Psychotherapy, Philipps University of Marburg, Germany.
Nooshin JavaheripourDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany.
Martin WalterDepartment of Psychiatry and Psychotherapy, Jena University Hospital, Jena, Germany; Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
Carlos A ZarateExperimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Funding

Glutamatergic Modulators for Rapid & Sustained Antidepressant EffectZIAMH002857 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2009 to 2025
$55.0M
NIMH MEG Core FacilityZICMH002889 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI NUGENT, ALLISON · 2009 to 2025
$31.4M
Intramural NIH HHS ZIA MH002857
6 · The paper itself

Abstract

Music and ketamine are both known to affect therapeutic outcomes, but few studies have investigated their co-administration. This scoping review describes the existing literature on the joint use of music and ketamine-or esketamine (the S(+) enantiomer of ketamine)-in humans. The review considers that extant studies have explored the intersection of ketamine/esketamine and music in healthy volunteers and in patients of various age groups, at different dosages, through different treatment processes, and have varied the sequence of playing music relative to ketamine/esketamine administration. Studies investigating the use of music during ketamine anesthesia are also included in the review because anesthesia and sedation were the early drivers of ketamine use. Studies pertaining to recreational ketamine use were omitted. The review was limited to articles published in the English language but not restricted by publication year. To the best of our knowledge, this scoping review is the first comprehensive exploration of the interplay between music and ketamine/esketamine and offers valuable insights to researchers interested in designing future studies.

Indexed as

KetamineMusic TherapyAnesthetics, DissociativeDepressionHumansPain ManagementAnesthetics, DissociativeEsketamineKetamineAnesthesiaEsketamineKetamineMusic

Identifiers

PMID38697379
PMCPMC13179047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.